Are We Overpromising Healing Results? | Conversations in Regen Episode 6

Are we truly helping patients heal—or just selling hope? Are we overpromising healing results to our patients in the booming field of orthobiologics? And if cultured stem cells really offer better outcomes, why can’t we use them in the U.S. yet? These are the difficult but necessary questions we dive into in this eye-opening episode of Conversations in Regenerative Medicine featuring Dr. John Pitts.In this candid and richly informative discussion, we explore the promises and pitfalls of regenerative medicine, particularly in the context of platelet rich plasma injection (PRP), bone marrow concentrate (BMC), and cultured mesenchymal stem cells. Are we, as providers, genuinely guiding our patients to the best available treatment—or are we too often navigating the gray zone between science and marketing? With a market now worth $4 billion, orthobiologics is under more scrutiny than ever, and the question lingers: are we overpromising healing results to our patients?Dr. Pitts shares his nuanced experience in regenerative orthopedics and sports medicine, unpacking how regenerative treatments can be powerful—but only when used with precision, transparency, and the right patient profile. We break down the current PRP therapy and stem cell research, compare intraosseous versus intraarticular injections, and discuss whether we’re ready for global guidelines or still stuck in the “wild west” of regenerative medicine. We also reflect on the ethical implications of access, affordability, and whether withholding regenerative care because of insurance limitations is, in itself, unethical.You’ll hear real clinical insights from over a decade of advanced regenerative orthopedics work, as well as practical takeaways on patient communication, outcome tracking, and the delicate balance between data, hope, and honesty. This is a must-watch for any practitioner navigating the challenges and breakthroughs of regenerative medicine orthopedics today.If you’re passionate about staying ahead in regenerative orthopedics—or simply want a clearer framework to counsel your patients—this conversation delivers clarity without hype.Building a successful cash-based orthobiologic practice is not a single decision. It is a series of the right decisions made in the right order. The Business of Orthobiologics offers three distinct programs designed to meet physicians at different stages of readiness — whether you are just beginning to explore PRP, ready to build a full practice system, or committed to going all-in on a comprehensive transformation.Learn More here: https://thebusinessoforthobiologics.com/programs-explanation _______________________________________________________Follow us and subscribe to our links below ⏬⏬⏬Website: businessoforthobiologics.comApple Podcast: apple.co/3Azvt3RSpotify: spoti.fi/3oICYmhYoutube: bit.ly/drariana